Dariohealth Corp Stock Today
| DRIO Stock | USD 0.72 0.04 5.88% |
PerformanceInsignificant
| Odds Of DistressHigh
|
DarioHealth Corp is selling at 0.72 as of the 19th of March 2025; that is 5.88% increase since the beginning of the trading day. The stock's open price was 0.68. DarioHealth Corp has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 6th of October 2014 | Category Healthcare | Classification Health Care |
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York. Dario Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 41.57 M outstanding shares of which 2.8 M shares are currently shorted by private and institutional investors with about 4.77 trading days to cover. More on DarioHealth Corp
Moving against DarioHealth Stock
DarioHealth Stock Highlights
| Chairman, CEO and Pres | Erez Raphael | |||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Medical Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Medical Equipment, Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsDarioHealth Corp can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand DarioHealth Corp's financial leverage. It provides some insight into what part of DarioHealth Corp's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
DarioHealth Corp (DRIO) is traded on NASDAQ Exchange in USA. It is located in 322 W 57th St, New York, NY, United States, 10019 and employs 249 people. DarioHealth Corp is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 28.26 M. DarioHealth Corp conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 41.57 M outstanding shares of which 2.8 M shares are currently shorted by private and institutional investors with about 4.77 trading days to cover.
DarioHealth Corp currently holds about 67.95 M in cash with (38.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check DarioHealth Corp Probability Of Bankruptcy
Ownership AllocationDarioHealth Corp holds a total of 41.57 Million outstanding shares. DarioHealth Corp retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check DarioHealth Ownership Details
DarioHealth Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Citadel Advisors Llc | 2024-12-31 | 71.9 K | |
| Northern Trust Corp | 2024-12-31 | 64.6 K | |
| Clarity Capital Partners Llc | 2024-12-31 | 28.2 K | |
| Xtx Topco Ltd | 2024-12-31 | 24.8 K | |
| The Colony Group Llc | 2024-12-31 | 24 K | |
| Susquehanna International Group, Llp | 2024-12-31 | 21.8 K | |
| Marco Investment Management Llc | 2024-12-31 | 19.2 K | |
| Klingman And Associates, Llc | 2024-12-31 | 17.9 K | |
| Pathstone Holdings Llc | 2024-12-31 | 15.4 K | |
| Nantahala Capital Management, Llc | 2024-12-31 | 2.4 M | |
| Appian Way Asset Management | 2024-12-31 | 1.4 M |
DarioHealth Corp Historical Income Statement
DarioHealth Stock Against Markets
DarioHealth Corp Corporate Management
| Lara Dodo | Chief Officer | Profile | |
| Tomer BenKiki | Chief Officer | Profile | |
| Josh Fischer | Senior Compliance | Profile | |
| Dov Oppenheim | CoFounder Chief | Profile | |
| Brian Harrigan | Senior Sales | Profile | |
| Richard Anderson | President | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.61) | Revenue Per Share | Quarterly Revenue Growth 1.103 | Return On Assets | Return On Equity |
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.